Recognizing potential risks don’t always manifest during mandatory clinical trials required for the approval of medical devices, the Food and Drug Administration (FDA) has launched a Web site, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas.cfm, which provides updates on post-approval studies.

The site currently lists 44 records on FDA-ordered post-approval device studies.